Phio Pharmaceuticals Corp expected to post a loss of $3.24 a share - Earnings Preview

Phio Pharmaceuticals

17/03/2023 11:14

* Phio Pharmaceuticals Corp  PHIO.OQ   PHIO.O  is expected
to show
no change in quarterly revenue when it reports  results on March
20 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Phio
Pharmaceuticals Corp
is for a loss of $3.24 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $72​, above​ its last closing price
of $5.69. ​​​

This summary was machine generated March 17 at 11:14 GMT.  All
figures in US dollars  unless otherwise stated